Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Comparison of metastatic versus non-metastatic breast cancer at the time of diagnosis and risk factors for primary metastatic breast cancer

Mesut YUR.




Abstract

Objective: The most common type of cancer in women is breast cancer. Despite an increase in the rate of early detection, distant organ metastasis is still seen at the time of diagnosis. The purpose of this study was to identify the predictive risk factors for breast cancer patients with distant organ metastases and to compare them to those without distant organ metastases.
Materials and Methods: The study included data from patients who applied to our clinic for follow-up or treatment between January 2020 and July 2020. After meeting the exclusion criteria, the remaining 115 patients were included in the study. Study participants were divided into two groups: metastatic (group I) and non-metastatic (group II). Logistic regression analysis is used to assess the predictive risk factors.
Results: There is a significant difference between groups in terms of the breast side, T-stage, N-stage, CA 15-3, and albumin levels (p< 0.05). In univariate analyses, T-stage, CA 15-3, estimates glomerular filtration rate (eGFR), alkaline phosphatase, and albumin levels were statistically found to be significant (p

Key words: Breast cancer; Metastasis; CA 15-3; Albumin.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.